Debra A. Heller, PhD
Advertisement
Articles by Debra A. Heller, PhD
Advertisement
Latest Updated Articles
- Changes in Related Drug Class Utilization after Market Withdrawal of Cisapride
Published: March 1st 2002 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
2
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
3
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD
4
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
5
